Trial intelligence / Profile preview

Effect of erythropoietin on anemia of prematurity

IRCT201112265110N2Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Dec 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of erythropoietin in anemia of prematurity (AOP), sponsored by Hamadan University of Medical Sciences. Started Dec 2008; status: completed.

02

Drugs

erythropoietin
03

Conditions

anemia of prematurity (AOP)

Beyond the preview

Go deeper on IRCT201112265110N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201112265110N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call